Pfizer Ltd.
BSE: 500680 | Sector: Health care |
NSE: PFIZER | ISIN Code: INE182A01018 |
BSE 00:00 | 24 May | 4258.60 |
-148.75 (-3.38%) |
OPEN
4395.30 |
HIGH
4395.30 |
LOW
4225.85 |
NSE 00:00 | 24 May | 4260.40 |
-151.60 (-3.44%) |
OPEN
4400.00 |
HIGH
4403.60 |
LOW
4215.00 |
OPEN | 4395.30 |
PREVIOUS CLOSE | 4407.35 |
VOLUME | 654 |
52-Week high | 6164.80 |
52-Week low | 4077.80 |
P/E | 31.80 |
Mkt Cap.(Rs cr) | 19,483 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Pfizer Ltd.
Pfizer Limited is engaged in manufacturing marketing trading and export of pharmaceutical products. The company is a subsidiary of Pfizer Inc. the world's premiere biopharmaceutical corporation with annual revenues of $52.5 billion in 2017. Pfizer Limited has a portfolio of over 150 products across 15 therapeutic areas. Its top brands include Prevenar 13 Lyrica Eliquis Enbrel Becosules Gelusil and...> More
Pfizer Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
19,483 | |
EPS - TTM | (![]() |
[*S] | 133.90 |
P/E Ratio | (X) | [*S] | 31.80 |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | 300.00 | |
Latest Dividend Date | 11 Aug 2021 | ||
Dividend Yield | (%) | 0.79 | |
Book Value / Share | (![]() |
[*S] | 626.13 |
P/B Ratio | (![]() |
[*S] | 6.80 |
News
Pfizer Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 549.66 | 534.76 | 2.79 |
Other Income | 17.12 | 37.2 | -53.98 |
Total Income | 566.78 | 571.96 | -0.91 |
Total Expenses | 384.21 | 409.02 | -6.07 |
Operating Profit | 182.57 | 162.94 | 12.05 |
Net Profit | 125.79 | 100.55 | 25.1 |
Equity Capital | 45.75 | 45.75 | - |
Pfizer Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Glaxosmi. Pharma | 1553.75 | -0.08 | 26322.08 |
Ipca Labs. | 955.60 | -2.20 | 24243.57 |
Syngene Intl. | 547.25 | -2.11 | 21968.26 |
Pfizer | 4258.60 | -3.38 | 19483.10 |
Sanofi India | 6587.80 | -0.73 | 15171.70 |
Alembic Pharma | 756.35 | -0.53 | 14866.06 |
Ajanta Pharma | 1699.30 | -1.55 | 14512.02 |
Pfizer Ltd - SHAREHOLDING PATTERN
|
|
Pfizer Ltd - Research Reports
Date | Broker | Action | Price | Report |
08/11/2021 | ICICI Securities | Hold | 5008 | ![]() |
30/07/2021 | ICICI Direct.com Research | Hold | 5778 | ![]() |
27/05/2021 | ICICI Securities | Hold | 5266 | ![]() |
15/07/2020 | Centrum Broking | Buy | 4133 | ![]() |
16/06/2020 | ICICI Securities | Buy | 4078 | ![]() |
Pfizer Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 0.36% | 0.35% | -0.49% | -0.83% |
1 Month | -2.07% | -2.02% | -5.50% | -6.10% |
3 Month | 0.87% | 0.85% | -0.88% | -0.76% |
6 Month | -14.00% | -13.80% | -7.35% | -7.41% |
1 Year | -18.76% | -18.74% | 6.71% | 6.10% |
3 Year | 35.21% | 35.27% | 37.07% | 36.15% |
Pfizer Ltd - STOCK STRENGTH
Today's Low/High | 4225.85 | 4395.30 | |
Week Low/High | 4175.00 | 4498.00 | |
Month Low/High | 4077.80 | 4498.00 | |
YEAR Low/High | 4077.80 | 6165.00 | |
All TIME Low/High | 25.00 | 6165.00 |
Quick Links for Pfizer:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices